Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2006 1
2008 1
2010 2
2011 1
2013 1
2014 1
2015 1
2017 2
2019 5
2020 4
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Femminella GD, Livingston NR, Raza S, van der Doef T, Frangou E, Love S, Busza G, Calsolaro V, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood B, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Passmore AP, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Tan T, Holscher C, Harrison J, Brooks DJ, Ballard C, Edison P. Femminella GD, et al. Among authors: karim s. Alzheimers Res Ther. 2021 Feb 17;13(1):47. doi: 10.1186/s13195-021-00784-w. Alzheimers Res Ther. 2021. PMID: 33597002 Free PMC article.
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Femminella GD, et al. Among authors: karim s. Trials. 2020 Jul 19;21(1):660. doi: 10.1186/s13063-020-04608-4. Trials. 2020. PMID: 32684162 Free PMC article.
Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study.
Forsyth K, Heathcote L, Senior J, Malik B, Meacock R, Perryman K, Tucker S, Domone R, Carr M, Hayes H, Webb R, Archer-Power L, Dawson A, Leonard S, Challis D, Ware S, Emsley R, Sanders C, Karim S, Fazel S, Hayes A, Burns A, Piper M, Shaw J. Forsyth K, et al. Among authors: karim s. Southampton (UK): NIHR Journals Library; 2020 Jun. Southampton (UK): NIHR Journals Library; 2020 Jun. PMID: 32609458 Free Books & Documents. Review.
A roadmap to develop dementia research capacity and capability in Pakistan: A model for low- and middle-income countries.
Leroi I, Chaudhry N, Daniel A, Dunne R, Eman S, Farina N, Haidry SE, Husain N, Jafri H, Karim S, Kiran T, Khan M, Khan Q, Malik SJ, Memon R, Rana MH, Sathish A, Sheikh S, Tamizudin A, Tofique S, Zadeh Z; Pakistan Dementia Research Stakeholder Group (PDRSG). Leroi I, et al. Among authors: karim s. Alzheimers Dement (N Y). 2019 Dec 28;5:939-952. doi: 10.1016/j.trci.2019.11.005. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31921968 Free PMC article. Review.
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Femminella GD, et al. Among authors: karim s. Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x. Trials. 2019. PMID: 30944040 Free PMC article. Clinical Trial.
23 results